Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Pharmacy (Basel, Switzerland)|April 11, 2020
Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple SclerosisIciar Martínez-López, Jorge Maurino, Patricia Sanmartín-Fenollera, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Sick leave and occupational burnout among nurses caring for patients with multiple sclerosisGustavo Saposnik, Guillermo Bueno-Gil, Ángel P Sempere, et al.
Neuropsychiatric Disease and Treatment|August 5, 2025
Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural DeterminantsEnric Monreal, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 15, 2025
How do neurologists perceive the organization and functioning of multiple sclerosis care units?Lamberto Landete, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 18, 2019
Perception of stigma in patients with primary progressive multiple sclerosisFrancisco Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.
Multiple Sclerosis and Related Disorders|March 1, 2021
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)Francisco Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.
Journal of Personalized Medicine|February 25, 2025
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive ImpairmentJosé M García-Domínguez, Jorge Maurino, José E Meca-Lallana, et al.
Brain and Behavior|January 24, 2021
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosisFrancisco Carlos Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.
Multiple Sclerosis and Related Disorders|August 31, 2024
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?Gustavo Saposnik, Enric Monreal, Nicolas Medrano, et al.
Neurology and Therapy|May 6, 2022
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional StudyJosé E Meca-Lallana, Rocío Gómez-Ballesteros, Francisco Pérez-Miralles, et al.
Pageof 9